ScholarIQanswers from OpenAlex

Fasudil, a rho kinase inhibitor, limits motor neuron loss in experimental models of amyotrophic lateral sclerosis

PaperCitations, authors & open-access status

Fasudil, a rho kinase inhibitor, limits motor neuron loss in experimental models of amyotrophic lateral sclerosis is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Fasudil, a rho kinase inhibitor, limits motor neuron loss in experimental models of amyotrophic lateral sclerosis have?

ScholarIQcitation count

Fasudil, a rho kinase inhibitor, limits motor neuron loss in experimental models of amyotrophic lateral sclerosis has 129 citations in the OpenAlex counts ScholarIQ stores.

When was Fasudil, a rho kinase inhibitor, limits motor neuron loss in experimental models of amyotrophic lateral sclerosis published?

ScholarIQyear

Fasudil, a rho kinase inhibitor, limits motor neuron loss in experimental models of amyotrophic lateral sclerosis has 2013 year in the ScholarIQ index.

What is the open-access status of Fasudil, a rho kinase inhibitor, limits motor neuron loss in experimental models of amyotrophic lateral sclerosis?

ScholarIQoa status

Fasudil, a rho kinase inhibitor, limits motor neuron loss in experimental models of amyotrophic lateral sclerosis has bronze oa status in the ScholarIQ index.

What is the DOI of Fasudil, a rho kinase inhibitor, limits motor neuron loss in experimental models of amyotrophic lateral sclerosis?

ScholarIQdoi

The DOI for Fasudil, a rho kinase inhibitor, limits motor neuron loss in experimental models of amyotrophic lateral sclerosis is on the source record.

What is the PMID of Fasudil, a rho kinase inhibitor, limits motor neuron loss in experimental models of amyotrophic lateral sclerosis?

ScholarIQpmid

The PMID for Fasudil, a rho kinase inhibitor, limits motor neuron loss in experimental models of amyotrophic lateral sclerosis is on the source record.

What is the OpenAlex record for Fasudil, a rho kinase inhibitor, limits motor neuron loss in experimental models of amyotrophic lateral sclerosis?

ScholarIQopenalex

The OpenAlex for Fasudil, a rho kinase inhibitor, limits motor neuron loss in experimental models of amyotrophic lateral sclerosis is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial